REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Silacorsa S.A. (Ecuador)

Main Activities: General Medical and Surgical Hospitals
Full name: Silacorsa S.A. Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Silacorsa S.A operates in the medical health industry, offering specialized services for respiratory pathologies, sleep disorders, and aerosol therapy. The company uses advanced German technology for comprehensive sleep diagnosis and treatment, as well as pulse and vibratory aerosol therapy for sinusitis. They also provide home adequacy services and pulmonary physiotherapy for respiratory diseases.

Headquarters
Abel Romeo Castillo, Omnihospital Bldg.
Guayaquil; Guayas;

Contact Details: Purchase the Silacorsa S.A. report to view the information.

Website: http://www.respir02.com

Basic Information
Total Employees:
Purchase the Silacorsa S.A. report to view the information.
Registered Capital:
Purchase the Silacorsa S.A. report to view the information.
Financial Auditors:
Purchase the Silacorsa S.A. report to view the information.
Incorporation Date:
September 08, 2008
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
66.75%
Purchase this report to view the information.
25%
Purchase this report to view the information.
8.25%
Company Performance
Financial values in the chart are available after Silacorsa S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
17.1%▲
Total operating revenue
17.1%▲
Operating profit (EBIT)
26.59%▲
EBITDA
5.63%▲
Net Profit (Loss) for the Period
26.83%▲
Total Assets
2.6%▲
Total Equity
12.33%▲
Operating Profit Margin (ROS)
0.9%▲
Net Profit Margin
0.92%▲
Return on Equity (ROE)
5.93%▲
Quick Ratio
2.36%▲
Cash Ratio
0.6%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo